π― Focus of the Conference
The 2nd World Congress on Diabetes and Endocrinology β 2026, under the theme "Practical Approach in Treating Diabetes and Endocrinal Disorder", is strategically designed to explore the most current, evidence-based, and clinically impactful developments in endocrinology and diabetology. The congress will provide a dynamic platform for deep scientific engagement, clinical insight, and translational innovation.
- 𧬠Emerging Therapies in Diabetes Management
Explore novel pharmacologic agents including dual and triple agonists (e.g., GLP-1/GIP receptor co-agonists), small-molecule insulin sensitizers, and oral semaglutide. Delve into personalized insulin therapy, beta-cell preservation strategies, and immune modulation in type 1 diabetes.
- π§ Precision Endocrinology and Genomic Medicine
Understand how genomics, epigenetics, and single-cell sequencing are redefining endocrine disease classification and enabling precision diagnosis and individualized therapy for thyroid disorders, adrenal pathologies, and genetic syndromes.
- π€ Diabetes Technology and Digital Health
Examine the clinical integration of advanced diabetes technologies such as automated insulin delivery systems (AID), continuous glucose monitoring (CGM), wearable biosensors, mobile health applications, and artificial intelligence for clinical decision support.
- π Cardio-Renal-Metabolic Interventions
Review the evolving role of SGLT2 inhibitors and GLP-1 receptor agonists in reducing cardiovascular events and renal progression in people with type 2 diabetes, as well as new agents targeting metabolic inflammation and lipotoxicity.
- π©Ί Endocrine-Oncology and Rare Hormonal Disorders
Explore innovations in the management of endocrine malignancies (thyroid cancer, adrenal tumors, pituitary adenomas), paraneoplastic syndromes, and rare genetic endocrine syndromes through a combination of molecular diagnostics and targeted therapies.
- π§ͺ Translational and Experimental Endocrinology
Gain insight into bench-to-bedside research, including stem-cell derived islet transplantation, gene therapy for monogenic diabetes, and advances in endocrine disruptor science.
- π Global Health, Health Equity & Chronic Disease Prevention
Discuss the social and structural determinants of diabetes care, innovations in low-resource settings, and large-scale prevention programs addressing obesity, lifestyle, and environmental risks.
- π Practical Skills and Real-World Case Studies
Participate in hands-on workshops, multidisciplinary panel discussions, and live case-based sessions that emphasize the application of guidelines to daily practice, including management of diabetic foot, hyperglycemic crises, and endocrine emergencies.
The congress aims to translate scientific discovery into clinical excellence, preparing healthcare professionals and researchers to lead the next wave of innovation in diabetes care and endocrine health.